文献速递新发突发、热带与寄生虫病艾滋病与性传播感染

沉默的流行病:美国年轻无症状高危女性中生殖支原体的患病率、发病率与持续性

A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States.
PubMed 文献 · Clin Infect Dis · 2018-01-01

研究前瞻性随访15-25岁无症状细菌性阴道病且≥2项性传播感染危险因素的女性,从美国10个中心招募,入组时及此后每2个月经家庭自采样检测生殖支原体至12个月。1139名女性中生殖支原体患病率为20.5%(95%CI 18.2%-22.9%),204例中42例为持续性感染(20.6%);801名基线阴性者发病率为36.6/100人年(95%CI 32.4-41.3)。

要点

  • 1139名年轻无症状高危女性中生殖支原体患病率为20.5%(95%CI 18.2%-22.9%)。
  • 基线阴性者生殖支原体发病率为36.6/100人年(95%CI 32.4-41.3)。
  • 作者认为需开展临床试验评估生殖支原体筛查对女性生殖健康结局的影响。

核心结论

  • 在无症状细菌性阴道病的年轻高危女性中,生殖支原体的患病率、发病率和持续感染率均较高,作者认为需开展临床试验评估生殖支原体筛查对女性生殖健康结局的影响。

研究设计与样本

  • 前瞻性研究,分析无症状细菌性阴道病研究中收集的数据,以确定生殖支原体的自然史。
  • 从美国10个中心招募15-25岁、有无症状细菌性阴道病且≥2项性传播感染危险因素的女性。
  • 入组时采集阴道拭子,此后12个月内每2个月经家庭自采样检测,采用转录介导扩增试验(Hologic)行生殖支原体核酸检测。
  • 共纳入1139名女性,其中基线生殖支原体阴性者801名。

主要发现

  • 1139名女性中233例生殖支原体阳性,患病率为20.5%(95%CI 18.2%-22.9%)。
  • 204例中42例为持续性生殖支原体感染(20.6%),持续性定义为随访期间所有标本均阳性。
  • 801名基线阴性女性的生殖支原体发病率为36.6/100人年(95%CI 32.4-41.3)。
  • 黑人种族(AOR 1.92;95%CI 1.09-3.38)、年龄≤21岁(AOR 1.40;95%CI 1.03-1.91)和既往妊娠(AOR 1.36;95%CI 1.00-1.85)与现患生殖支原体感染相关。
  • 仅黑人种族与 incident 生殖支原体感染相关(P=0.03)。

关键数值与推荐

  • 生殖支原体患病率为20.5%(95%CI 18.2%-22.9%),对象为1139名15-25岁无症状细菌性阴道病且≥2项性传播感染危险因素的女性。
  • 持续性生殖支原体感染为204例中42例(20.6%),持续性定义为随访期间所有标本均阳性。
  • 生殖支原体发病率为36.6/100人年(95%CI 32.4-41.3),对象为801名基线生殖支原体阴性女性。
  • 黑人种族与现患生殖支原体感染的AOR为1.92(95%CI 1.09-3.38)。
  • 年龄≤21岁与现患生殖支原体感染的AOR为1.40(95%CI 1.03-1.91),既往妊娠的AOR为1.36(95%CI 1.00-1.85)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mycoplasma genitalium can result in pelvic inflammatory disease and adverse pregnancy outcomes. We analyzed data collected from a prospective study of asymptomatic bacterial vaginosis (BV) to determine the natural history of M. genitalium. METHODS: Women aged 15-25 years, with asymptomatic BV and ≥2 risk factors for sexually transmitted infection were recruited from 10 sites throughout the United States. Vaginal swab samples were collected at enrollment and through home-based testing every 2 months over 12 months. M. genitalium nucleic acid amplification testing was performed for M. genitalium using transcription-mediated assays (Hologic). The prevalence, incidence, and persistence of M. genitalium, defined as all positive specimens during follow-up, were estimated with 95% confidence intervals (CIs). Adjusted odds ratios (AOR) were calculated using logistic and Poisson regression to evaluate participant characteristics associated with M. genitalium infection. RESULTS: Among 1139 women, 233 were M. genitalium positive, for a prevalence of 20.5% (95% CI, 18.2%-22.9%); 42 of 204 had persistent M. genitalium (20.6%). Among 801 M. genitalium-negative women at baseline, the M. genitalium incidence was 36.6 per 100 person-years (95% CI, 32.4-41.3). Black race (AOR, 1.92; 95% CI, 1.09-3.38), age ≤21 years (1.40; 1.03-1.91), and prior pregnancy (1.36; 1.00-1.85) were associated with prevalent M. genitalium; only black race was associated with incident M. genitalium (P = .03). CONCLUSIONS: We identified high rates of prevalent, incident, and persistent M. genitalium infections among young, high-risk women with asymptomatic BV, supporting the need for clinical trials to evaluate the impact of M. genitalium screening on female reproductive health outcomes.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Seña AC, Lee JY, Schwebke J, et al. A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States. Clin Infect Dis. 2018. PMID: 29342269. doi:10.1093/cid/ciy025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。